Literature DB >> 24648899

Excess iron undermined bone load-bearing capacity through tumor necrosis factor-α-dependent osteoclastic activation in mice.

Junping Li1, Yanli Hou1, Shuping Zhang2, Hong Ji3, Haiqin Rong3, Guangbo Qu2, Sijin Liu2.   

Abstract

Iron overload has been associated with bone mass loss. To elucidate the effects of excess iron on bone metabolism, an iron-overloading mouse model was established by administering iron-dextran at 250 mg/kg to female BALB/c mice. After 4 weeks, the mice were sacrificed and the biomechanical properties of the femurs were examined. The results suggested a notable decrease of the maximal bending stress and the modulus of bending elasticity in the femurs obtained from the excess iron-treated mice compared to the control mice. The levels of the serum osteocalcin, C-telopeptide of type I collagen (CTX-1) and tumor necrosis factor-α (TNF-α) were measured in order to investigate the underlying mechanism responsible for the excess iron-induced bone strength reduction. Overall, the results suggested that iron overload resulted in a marked reduction of bone load-bearing capacity through a TNF-triggered osteoclast differentiation and resorption mechanism.

Entities:  

Keywords:  bone mass; bone resorption; bone strength; iron overload

Year:  2012        PMID: 24648899      PMCID: PMC3956768          DOI: 10.3892/br.2012.6

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  24 in total

1.  Improved bone biomechanical properties in rats after oral xylitol administration.

Authors:  P Mattila; M Knuuttila; V Kovanen; M Svanberg
Journal:  Calcif Tissue Int       Date:  1999-04       Impact factor: 4.333

2.  Mechanical strain, induced noninvasively in the high-frequency domain, is anabolic to cancellous bone, but not cortical bone.

Authors:  C Rubin; A S Turner; C Mallinckrodt; C Jerome; K McLeod; S Bain
Journal:  Bone       Date:  2002-03       Impact factor: 4.398

3.  TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL.

Authors:  Karen Fuller; Chiho Murphy; Barrie Kirstein; Simon W Fox; Timothy J Chambers
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

4.  The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action.

Authors:  Y B Niu; Y H Li; X H Kong; R Zhang; Y Sun; Q Li; C Li; L Liu; J Wang; Q B Mei
Journal:  Osteoporos Int       Date:  2012-04-26       Impact factor: 4.507

5.  Dietary iron positively influences bone mineral density in postmenopausal women on hormone replacement therapy.

Authors:  Jaclyn Maurer; Margaret M Harris; Vanessa A Stanford; Timothy G Lohman; Ellen Cussler; Scott B Going; Linda B Houtkooper
Journal:  J Nutr       Date:  2005-04       Impact factor: 4.798

6.  Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors:  Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

7.  Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis.

Authors:  Qing Yang; Jinlong Jian; Steven B Abramson; Xi Huang
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

8.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

9.  Excess iron inhibits osteoblast metabolism.

Authors:  Kanako Yamasaki; Hiromi Hagiwara
Journal:  Toxicol Lett       Date:  2009-09-06       Impact factor: 4.372

10.  Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.

Authors:  Youridies Vattakuzhi; Sonya M Abraham; Andrew Freidin; Andrew R Clark; Nicole J Horwood
Journal:  Arthritis Rheum       Date:  2012-07
View more
  4 in total

Review 1.  Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Charlene M Williams; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2022-02-10       Impact factor: 4.592

2.  Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

Authors:  Cyril Renassia; Sabine Louis; Sylvain Cuvellier; Nadia Boussetta; Jean-Christophe Deschemin; Didier Borderie; Karine Bailly; Joel Poupon; Pham My-Chan Dang; Jamel El-Benna; Sandra Manceau; François Lefrère; Sophie Vaulont; Carole Peyssonnaux
Journal:  Blood Adv       Date:  2020-08-25

3.  Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone.

Authors:  Zhong-Kui Xiong; Juan Lang; Gang Xu; Hai-Yu Li; Yun Zhang; Lei Wang; Yao Su; Ai-Jing Sun
Journal:  Exp Ther Med       Date:  2014-12-02       Impact factor: 2.447

4.  New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis.

Authors:  Wenya Feng; Yuanjing Xiao; Chuanfang Zhao; Zhanming Zhang; Wei Liu; Juan Ma; Tomas Ganz; Junliang Zhang; Sijin Liu
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.